T1	Participants 93 98	COPD.
T2	Participants 249 340	patients with stable and partially reversible chronic obstructive pulmonary disease (COPD).
T3	Participants 341 399	Sixteen outpatients with partially reversible, stable COPD
T4	Participants 1863 1946	patients suffering from partially reversible chronic obstructive pulmonary disease.
